The cell line NCL-H69 of human small-cell lung carcinoma was chosen for in vivo experiments because it has a mutation in the P53 gene (p.E171*), a moderate sensitivity to etoposide [28], and is widely used for studies of chemoresistance of cancer [29–31]. The gene discussed is TP53; the disease is cancer.